位置:首页 > 蛋白库 > GALNS_MOUSE
GALNS_MOUSE
ID   GALNS_MOUSE             Reviewed;         520 AA.
AC   Q571E4; Q3TWQ4; Q99KU8; Q9JHK9;
DT   23-JAN-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   03-AUG-2022, entry version 120.
DE   RecName: Full=N-acetylgalactosamine-6-sulfatase;
DE            EC=3.1.6.4;
DE   AltName: Full=Chondroitinsulfatase;
DE            Short=Chondroitinase;
DE   AltName: Full=Galactose-6-sulfate sulfatase;
DE   AltName: Full=N-acetylgalactosamine-6-sulfate sulfatase;
DE            Short=GalNAc6S sulfatase;
DE   Flags: Precursor;
GN   Name=Galns;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=129/SvJ, and C57BL/6J;
RX   PubMed=10699374; DOI=10.1016/s0925-4439(99)00119-2;
RA   Montano A.M., Yamagishi A., Tomatsu S., Fukuda S., Copeland N.G.,
RA   Orii K.E., Isogai K., Yamada N., Kato Z.I., Jenkins N.A., Gilbert D.J.,
RA   Sukegawa K., Orii T., Kondo N.;
RT   "The mouse N-acetylgalactosamine-6-sulfate sulfatase (Galns) gene: cDNA
RT   isolation, genomic characterization, chromosomal assignment and analysis of
RT   the 5'-flanking region.";
RL   Biochim. Biophys. Acta 1500:323-334(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreatic islet;
RA   Okazaki N., Kikuno R.F., Ohara R., Inamoto S., Seino S., Nishimura M.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene. The
RT   complete nucleotide sequences of mouse KIAA-homologous cDNAs identified by
RT   screening of terminal sequences of cDNA clones randomly sampled from size-
RT   fractionated libraries.";
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Czech II; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Kidney, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Hydrolysis of the 6-sulfate groups of the N-acetyl-D-
CC         galactosamine 6-sulfate units of chondroitin sulfate and of the D-
CC         galactose 6-sulfate units of keratan sulfate.; EC=3.1.6.4;
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Lysosome {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Higher expression in liver and
CC       kidney. {ECO:0000269|PubMed:10699374}.
CC   -!- PTM: The conversion to 3-oxoalanine (also known as C-formylglycine,
CC       FGly), of a serine or cysteine residue in prokaryotes and of a cysteine
CC       residue in eukaryotes, is critical for catalytic activity.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the sulfatase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD90170.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF111346; AAF63155.1; -; mRNA.
DR   EMBL; AF112242; AAF63858.1; -; Genomic_DNA.
DR   EMBL; AF112230; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112231; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112233; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112232; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112234; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112235; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112236; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112237; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112238; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112239; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112240; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AF112241; AAF63858.1; JOINED; Genomic_DNA.
DR   EMBL; AK220245; BAD90170.1; ALT_INIT; mRNA.
DR   EMBL; AK159592; BAE35212.1; -; mRNA.
DR   EMBL; BC004002; AAH04002.1; -; mRNA.
DR   CCDS; CCDS40504.1; -.
DR   RefSeq; NP_001180574.1; NM_001193645.1.
DR   RefSeq; NP_057931.3; NM_016722.4.
DR   AlphaFoldDB; Q571E4; -.
DR   SMR; Q571E4; -.
DR   BioGRID; 206156; 2.
DR   STRING; 10090.ENSMUSP00000015171; -.
DR   GlyConnect; 2525; 3 N-Linked glycans (2 sites).
DR   GlyGen; Q571E4; 2 sites, 3 N-linked glycans (2 sites).
DR   PhosphoSitePlus; Q571E4; -.
DR   EPD; Q571E4; -.
DR   jPOST; Q571E4; -.
DR   MaxQB; Q571E4; -.
DR   PaxDb; Q571E4; -.
DR   PeptideAtlas; Q571E4; -.
DR   PRIDE; Q571E4; -.
DR   ProteomicsDB; 273414; -.
DR   Antibodypedia; 30794; 327 antibodies from 36 providers.
DR   DNASU; 50917; -.
DR   Ensembl; ENSMUST00000015171; ENSMUSP00000015171; ENSMUSG00000015027.
DR   GeneID; 50917; -.
DR   KEGG; mmu:50917; -.
DR   UCSC; uc012gmh.1; mouse.
DR   CTD; 2588; -.
DR   MGI; MGI:1355303; Galns.
DR   VEuPathDB; HostDB:ENSMUSG00000015027; -.
DR   eggNOG; KOG3867; Eukaryota.
DR   GeneTree; ENSGT00940000157787; -.
DR   HOGENOM; CLU_006332_13_5_1; -.
DR   InParanoid; Q571E4; -.
DR   OMA; IMHHMDW; -.
DR   OrthoDB; 515367at2759; -.
DR   PhylomeDB; Q571E4; -.
DR   TreeFam; TF314186; -.
DR   BRENDA; 3.1.6.4; 3474.
DR   Reactome; R-MMU-2022857; Keratan sulfate degradation.
DR   Reactome; R-MMU-6798695; Neutrophil degranulation.
DR   BioGRID-ORCS; 50917; 5 hits in 72 CRISPR screens.
DR   ChiTaRS; Galns; mouse.
DR   PRO; PR:Q571E4; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; Q571E4; protein.
DR   Bgee; ENSMUSG00000015027; Expressed in placenta labyrinth and 196 other tissues.
DR   ExpressionAtlas; Q571E4; baseline and differential.
DR   Genevisible; Q571E4; MM.
DR   GO; GO:0005764; C:lysosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0004065; F:arylsulfatase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043890; F:N-acetylgalactosamine-6-sulfatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008484; F:sulfuric ester hydrolase activity; ISO:MGI.
DR   CDD; cd16157; GALNS; 1.
DR   Gene3D; 3.40.720.10; -; 1.
DR   InterPro; IPR017850; Alkaline_phosphatase_core_sf.
DR   InterPro; IPR035626; GALNS.
DR   InterPro; IPR024607; Sulfatase_CS.
DR   InterPro; IPR000917; Sulfatase_N.
DR   Pfam; PF00884; Sulfatase; 1.
DR   SUPFAM; SSF53649; SSF53649; 1.
DR   PROSITE; PS00523; SULFATASE_1; 1.
PE   1: Evidence at protein level;
KW   Calcium; Disulfide bond; Glycoprotein; Hydrolase; Lysosome; Metal-binding;
KW   Reference proteome; Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000250"
FT   CHAIN           24..520
FT                   /note="N-acetylgalactosamine-6-sulfatase"
FT                   /id="PRO_0000273148"
FT   REGION          24..377
FT                   /note="Catalytic domain"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        76
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   ACT_SITE        139
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   BINDING         36
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         37
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         76
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /note="via 3-oxoalanine"
FT                   /evidence="ECO:0000250"
FT   BINDING         286
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         287
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         76
FT                   /note="3-oxoalanine (Cys)"
FT                   /evidence="ECO:0000250|UniProtKB:P15289"
FT   CARBOHYD        201
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        421
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        306..417
FT                   /evidence="ECO:0000250"
FT   DISULFID        487..516
FT                   /evidence="ECO:0000250"
FT   DISULFID        499..505
FT                   /evidence="ECO:0000250"
FT   CONFLICT        22
FT                   /note="A -> V (in Ref. 4; AAH04002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        154
FT                   /note="D -> N (in Ref. 1; AAF63858/AAF63155)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        207
FT                   /note="T -> L (in Ref. 4; AAH04002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        215
FT                   /note="Q -> R (in Ref. 4; AAH04002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        222
FT                   /note="S -> G (in Ref. 4; AAH04002)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        268
FT                   /note="S -> N (in Ref. 4; AAH04002)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   520 AA;  57673 MW;  63428DFA8843A21D CRC64;
     MAACTAAQQL LLVLSALGLL AAGAPQPPNI VLLLMDDMGW GDLGVNGEPS RETPNLDRMA
     AEGMLFPSFY SANPLCSPSR AALLTGRLPI RNGFYTTNAH ARNAYTPQEI MGGIPNSEHL
     LPELLKKAGY TNKIVGKWHL GHRPQFHPLK HGFDEWFGSP NCHFGPYDNK AKPNIPVYRD
     WEMVGRFYEE FPINRKTGEA NLTQLYTQEA LDFIQTQHAR QSPFFLYWAI DATHAPVYAS
     RQFLGTSLRG RYGDAVREID DSVGKILSLL QNLGISKNTF VFFTSDNGAA LISAPNEGGS
     NGPFLCGKQT TFEGGMREPA IAWWPGHIAA GQVSHQLGSI MDLFTTSLSL AGLKPPSDRV
     IDGLDLLPTM LKGQMMDRPI FYYRGNTLMA VTLGQYKAHL WTWTNSWEEF TQGTDFCPGQ
     NVSGVTTHTQ EEHTELPLIF HLGRDPGERF PLSFHSDEYQ DALSRTTQVV QEHQKSLVPG
     QPQLNVCNQA VMNWAPPGCE KLGKCLTPPE SVPEKCFWAH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024